Drugs / BAT2606
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05576454 | Sep 2022 → May 2023 | asthma | Bio-Thera Solutions | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAT2606 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05576454 ↗ |
| Route | Subcutaneous | “In this group, each subject will receive single subcutaneous injection of 100 mg BAT2606 Injection.” NCT05576454 ↗ |